Chronic wounds (like diabetic ulcers or stubborn lacerations) are generally "stuck" in the M1 inflammatory phase
BPC-157s primary signalling mechanisms are well-characterised: it activates VEGFR2, drives downstream ERK1/2 phosphorylation, and stimulates nitric oxide synthesis via the Akt-eNOS axis producing pro-angiogenic, fibroblast-activating, and extracellular matrix-stabilising effects in experimental models
Skin Glow (GHK-Cu + TB-500 + BPC-157) is a tri-peptide research formulation combining three peptides studied in laboratory environments for their roles in dermal signaling, tissue integrity, and extracellular matrix research
Fast-response, professional medical staff
Peptide Vials (GHRP-6, 10 mg each) At these microgram doses a 10 mg vial lasts well beyond a week, so only a few vials cover a full course